80 related articles for article (PubMed ID: 15880780)
61. mSEL-1L (Suppressor/enhancer Lin12-like) protein levels influence murine neural stem cell self-renewal and lineage commitment.
Cardano M; Diaferia GR; Cattaneo M; Dessì SS; Long Q; Conti L; Deblasio P; Cattaneo E; Biunno I
J Biol Chem; 2011 May; 286(21):18708-19. PubMed ID: 21454627
[TBL] [Abstract][Full Text] [Related]
62. Methodology and applications of disease biomarker identification in human serum.
Sahab ZJ; Semaan SM; Sang QX
Biomark Insights; 2007 Feb; 2():21-43. PubMed ID: 19662190
[TBL] [Abstract][Full Text] [Related]
63. KEGG spider: interpretation of genomics data in the context of the global gene metabolic network.
Antonov AV; Dietmann S; Mewes HW
Genome Biol; 2008; 9(12):R179. PubMed ID: 19094223
[TBL] [Abstract][Full Text] [Related]
64. Altered gene expression in mice selected for high maternal aggression.
Gammie SC; Auger AP; Jessen HM; Vanzo RJ; Awad TA; Stevenson SA
Genes Brain Behav; 2007 Jul; 6(5):432-43. PubMed ID: 16939635
[TBL] [Abstract][Full Text] [Related]
65. SEL1L affects human pancreatic cancer cell cycle and invasiveness through modulation of PTEN and genes related to cell-matrix interactions.
Cattaneo M; Fontanella E; Canton C; Delia D; Biunno I
Neoplasia; 2005 Nov; 7(11):1030-8. PubMed ID: 16331889
[TBL] [Abstract][Full Text] [Related]
66. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells.
Willipinski-Stapelfeldt B; Riethdorf S; Assmann V; Woelfle U; Rau T; Sauter G; Heukeshoven J; Pantel K
Clin Cancer Res; 2005 Nov; 11(22):8006-14. PubMed ID: 16299229
[TBL] [Abstract][Full Text] [Related]
67. SEL1L expression decreases breast tumor cell aggressiveness in vivo and in vitro.
Orlandi R; Cattaneo M; Troglio F; Casalini P; Ronchini C; Ménard S; Biunno I
Cancer Res; 2002 Jan; 62(2):567-74. PubMed ID: 11809711
[TBL] [Abstract][Full Text] [Related]
68. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
[TBL] [Abstract][Full Text] [Related]
69. Proteomic analysis of the E2F1 response in p53-negative cancer cells: new aspects in the regulation of cell survival and death.
Li Z; Kreutzer M; Mikkat S; Mise N; Glocker MO; Pützer BM
Proteomics; 2006 Nov; 6(21):5735-45. PubMed ID: 17001603
[TBL] [Abstract][Full Text] [Related]
70. Identification of 14-3-3sigma as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis.
Liu Y; Liu H; Han B; Zhang JT
Cancer Res; 2006 Mar; 66(6):3248-55. PubMed ID: 16540677
[TBL] [Abstract][Full Text] [Related]
71. Protein profiling comes of age.
Tomlinson IM; Holt LJ
Genome Biol; 2001; 2(2):REVIEWS1004. PubMed ID: 11182890
[TBL] [Abstract][Full Text] [Related]
72. Protein profile changes in the human breast cancer cell line MCF-7 in response to SEL1L gene induction.
Bianchi L; Canton C; Bini L; Orlandi R; Ménard S; Armini A; Cattaneo M; Pallini V; Bernardi LR; Biunno I
Proteomics; 2005 Jun; 5(9):2433-42. PubMed ID: 15880780
[TBL] [Abstract][Full Text] [Related]
73.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
74.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
75.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
76.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
